Download PDF
Horm Metab Res 2004; 36(3): 142-147
DOI: 10.1055/s-2004-814337
Original Basic
© Georg Thieme Verlag Stuttgart · New York

Impaired Erythrocyte Deformability Precedes Vascular Changes in Experimental Diabetes Mellitus

E.  J.  Diamantopoulos1 , C.  Kittas2 , D.  Charitos3 , M.  Grigoriadou1 , G.  Ifanti1 , S.  A.  Raptis3
  • 14th Department of Internal Medicine and Unit of Vascular Medicine, Evangelismos State General Hospital, Athens, Greece
  • 2Laboratory of Histology - Embryology, University of Athens Medical Faculty, Athens, Greece
  • 32nd Department of Internal Medicine - Propaedeutic, University of Athens Medical Faculty, Evangelismos State General Hospital, Athens, Greece
Further Information

Publication History

Received 8 July 2003

Accepted without revision 2 October 2003

Publication Date:
01 April 2004 (online)

Also available at
    Permissions and Reprints

Abstract

The effect of diabetes on the red blood cell (RBC) deformability and its association with histological vascular changes was investigated in 35 streptozotocin-induced diabetic Wistar rats in a 30-day experiment and compared to 10 controls. RBC deformability was significantly impaired in the diabetic rats on day 5 (p < 0.001) and continued to deteriorate until day 20. On the 20th day, the diabetic rats were randomly divided into two groups (group A: insulin-treated; group B: non-insulin-treated). A slight, non-significant (p = 0.20) improvement in RBC deformability was noticed in the insulin-treated group. In vitro incubation of RBCs with insulin did not improve the acquired RBC rigidity in either diabetic group. In contrast, it caused a significant reduction in RBC-deformability in the controls. On day 30, histological examination of arterial specimens from various sites revealed moderate to significant thickening in medium- and small-size artery and arteriole walls in both diabetic groups, with no evidence of diabetes-related changes in large, elastic-type arteries. No vascular changes were noticed in nine diabetic rats that succumbed between days 10 and 15. The results of this study indicate that reduced RBC deformability is an early manifestation of abnormal blood rheology in experimental diabetes, and precedes the evolution of vascular changes.

Key words

Erythrocyte deformability - Experimental diabetes - Diabetic angiopathy - Blood rheology

References

  • 1 Barnes A J, Locke P, Scudder P R, Dormandy T L, Dormandy J A, Slack J. Is hyperviscosity a treatable component of diabetic microcirculatory disease?.  Lancet. 1977;  2 (8042) 789-791
    PubMedGoogle Scholar
  • 2 Sagel J, Colwell J A, Crook L, Laimins M. Increased platelet aggregation in early diabetes mellitus.  Ann Intern Med. 1975;  82 733-738
    PubMedGoogle Scholar
  • 3 Baba Y, Kai M, Kamada T, Setoyama S, Otsuji S. Higher levels of erythrocyte membrane microviscosity in diabetes.  Diabetes. 1979;  28 1138-1140
    PubMedGoogle Scholar
  • 4 Schmid-Schönbein H, Volger E. Red-cell aggregation and red-cell deformability in diabetes.  Diabetes. 1976;  25 (Suppl 2) 897-902
    PubMedGoogle Scholar
  • 5 Wautier J L, Paton R C, Wautier M-P, Pintigny D, Abadie E, Passa P, Caen J P. Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications.  N Engl J Med. 1981;  305 237-242
    PubMedGoogle Scholar
  • 6 McMillan D E, Utterback N G, La Puma J. Reduced erythrocyte deformability in diabetes.  Diabetes. 1978;  27 895-901
    PubMedGoogle Scholar
  • 7 Ernst E, Matrai A. Altered red and white blood cell rheology in type II diabetes.  Diabetes. 1986;  35 1412-1415
    PubMedGoogle Scholar
  • 8 Diamantopoulos E J, Raptis S, Christodoulou M N, Moulopoulos S D. Impaired red blood cell deformability in diabetic angiopathy. The Royal Society of Medicine, London.  International Congress and Symposium Series. (1984);  No. 77 93-104
    PubMedGoogle Scholar
  • 9 Diamantopoulos E J, Raptis S A, Moulopoulos S D. Red blood cell deformability index in diabetic retinopathy.  Horm Metab Res. 1987;  19 569-573
    PubMedGoogle Scholar
  • 10 Diamantopoulos E J, Raptis S A, Karaiskos K, Mandel R, Moulopoulos S D. Erythrozytendeformabilität bei koronarkranken mit und ohne Diabetes mellitus. Verhandl Deut Gesel Innere Med. J.F. Bergmann Verlag München; (1981): 120-123
    Google Scholar
  • 11 Wu T J, Chuang L M, Tai T Y. Erythrocyte deformability in diabetes mellitus.  J Formosan Med Assoc. 1989;  88 240-243
    PubMedGoogle Scholar
  • 12 Carandente O, Colombo R, Girardi A M, Margonato A, Pozza G. Role of red cell sorbitol as determinant of reduced erythrocyte filtrability in insulin dependent diabetics.  Acta Diabetol Lat. 1982;  19 359-368
    PubMedGoogle Scholar
  • 13 Robey C, Dasmahapatra A, Cohen M P, Suarez S. Sorbinil partially prevents decreased erythrocyte deformability in experimental diabetes mellitus.  Diabetes. 1997;  36 1010-1013
    PubMedGoogle Scholar
  • 14 Vague P, Juhan I. Red cell deformability, platelet aggregation and insulin action.  Diabetes. 1983;  32 (Suppl 2) 88-91
    PubMedGoogle Scholar
  • 15 Prisco D, Paniccia R, Coppo M, Vanni D, Rogasi P G, Tramontana M, Abbate R, Gensini G F. Red blood cell lipid alterations in type II diabetes mellitus.  Thromb Res. 1989;  54 751-758
    CrossrefPubMedGoogle Scholar
  • 16 Garnier M, Attali J R, Valensi P, Delatour-Hanss E, Gaudey F, Koutsouris D. Erythrocyte deformability in diabetes and erythrocyte membrane lipid composition.  Metabolism. 1990;  39 794-798
    CrossrefPubMedGoogle Scholar
  • 17 Bryszewska M, Szosland K. Association between the glycation of erythrocyte membrane proteins and membrane fluidity.  Clin Biochem. 1988;  21 49-51
    PubMedGoogle Scholar
  • 18 Brown C, Zhao Z, Alaro F, Chan S, Friedman E. Correction of erythrocyte deformability defect in ALX-induced diabetic rabbits after treatment with aminoguanidine.  Diabetes. 1993;  16 590-593
    PubMedGoogle Scholar
  • 19 Symeonidis A, Athanassiou G, Psiroyiannis A, Kyriazopoulou V, Kapatais-Zoumbos K, Missirlis Y, Zoumbos N. Impairment of erythrocyte viscoelasticity is correlated with levels of glycosylated haemoglobin in diabetic patients.  Clin Lab Haematol. 2001;  23 103-109
    CrossrefPubMedGoogle Scholar
  • 20 International Committee for Standardization in Haematology . Guidelines for measurement of blood viscosity and erythrocyte deformability.  Clin Hemorheol. 1986;  6 439-453
    PubMedGoogle Scholar
  • 21 Heilmann L, Schmid-Schönbein H. Ein methodischer Beitrag zur Messung der Erythrozytenverformbarkeit.  Klin Wochenschr. 1981;  59 181-185
    CrossrefPubMedGoogle Scholar
  • 22 Chien S. Filterability and other methods of approaching red cell deformability. Determinants of blood viscosity and red cell deformability.  Scand J Clin Lab Invest Suppl. 1981;  156 7-12
    PubMedGoogle Scholar
  • 23 Koutsouris D. Etude des facteurs physiologiques de la deformabilité érythrocytaire. Thèse pour le Doctorat en Génie Biologique et Médical (Bioméchanique). Université de Paris XIII, U.E.R. Biomédicale de Bobigny 1982
    Google Scholar
  • 24 Juhan I, Vague P, Buonocore M, Moulin J P, Calas M F, Vialettes B, Verdott J J. Effect of insulin on erythrocyte deformability and platelet aggregation.  Scand J Clin Lab Invest Suppl. 1981;  156 159-164
    PubMedGoogle Scholar
  • 25 Juhan I, Vague P, Buonocore M, Moulin J P, Jouve R, Moulin J, Vialettes B. Abnormalities of erythrocyte deformability and platelet aggregation in insulin-dependent diabetics corrected by insulin in vivo and in vitro. .  Lancet. 1982;  1 (8271) 535-537
    PubMedGoogle Scholar
  • 26 Voisin P, Louis J, Vaillant G, Kollop S N, Gaillard S, Derby G, Stoltz J, Drouin P. Insulin has no influence in vitro on haemorheological parameters measured in poorly controlled diabetic patients.  Clin Haemorheol. 1983;  3 268-271
    PubMedGoogle Scholar
  • 27 Santini M T, Indovina P L, Simmons J R, Peterson S W. Human erythrocyte insulin receptor down-regulation is accompanied by a transient decrease in membrane order.  Biochim Biophys Acta. 1990;  1054 333-336
    PubMedGoogle Scholar
  • 28 Finotti P, Palatini P. Reduction of erythrocyte Na+-K+-ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma.  Diabetologia. 1986;  29 623-628
    CrossrefPubMedGoogle Scholar
  • 29 Ohtomo Y, Aperia A, Sahlgren B, Johansson B L, Wahren J. C-peptide stimulates rat renal tubular Na+-K+-ATPase activity in synergism with neuropeptide Y.  Diabetologia. 1996;  39 199-205
    CrossrefPubMedGoogle Scholar
  • 30 Ohtomo Y, Bergman T, Johansson B L, Jörnvall H, Wahren J. Differential effects of proinsulin C-peptide fragments on Na+-K+-ATPase activity of renal tubule segments.  Diabetologia. 1998;  41 287-291
    CrossrefPubMedGoogle Scholar
  • 31 Kunt T, Schneider S, Pfützner A, Goitum K, Engelbach M, Schauf B, Beyer J, Forst T. The effect of human proinsulin C-peptide on erythrocyte deformability in patients with type I diabetes mellitus.  Diabetologia. 1999;  42 465-471
    CrossrefPubMedGoogle Scholar
  • 32 Mavrikakis M E, Sfikakis P P, Kontoyannis D D, Horti M, Kittas C, Koutras D A, Raptis S A. Macrovascular disease of coronaries and cerebral arteries in streptozotocin-induced diabetic rats. A controlled, comparative study.  Exp Clin Endocrinol Diabetes. 1998;  106 35-40
    PubMedGoogle Scholar
  • 33 Rumble J R, Cooper M E, Soulis T, Cox A, Wu L, Youssef S, Jasik M, Jerums G, Gilbert R E. Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products.  J Clin Invest. 1997;  99 1016-1027
    PubMedGoogle Scholar
  • 34 Moore S A, Bohlen H G, Miller B G, Evan A P. Cellular and vessel wall morphology of cerebral cortical arterioles after short-term diabetes in adult rats.  Blood Vessels. 1985;  22 265-277
    PubMedGoogle Scholar
  • 35 Reinila A. Long-term effects of untreated diabetes on the arterial wall in rat. An ultrastructural study.  Diabetologia. 1981;  20 205-212
    PubMedGoogle Scholar
  • 36 Vranes D, Cooper M E, Dilley R J. Cellular mechanisms of diabetic vascular hypertrophy.  Microvasc Res. 1999;  57 8-18
    PubMedGoogle Scholar
  • 37 Jandeleit-Dahm K, Hannan K M, Farrelly C A, Allen T J, Rumble J R, Gilbert R E, Cooper M E, Little P J. Diabetes-induced vascular hypertrophy is accompanied by activation of Na(+)-H(+) exchange and prevented by Na(+)-H(+) exchange inhibition.  Circ Res. 2000;  87 1133-1140
    PubMedGoogle Scholar
  • 38 Bohlen H G, Hankins K D. Early arteriolar and capillary changes in streptozotocin-induced diabetic rats and intraperitoneal hyperglycaemic rats.  Diabetologia. 1982;  22 344-348
    PubMedGoogle Scholar
  • 39 Wehner H, Nelischer G. Morphometric investigations on intrarenal vessels of streptozotocin-diabetic rats.  Virchows Arch A Pathol Anat Histopathol. 1991;  419 231-235
    CrossrefPubMedGoogle Scholar
  • 40 Zatz R, Brenner B M. Pathogenesis of diabetic microangiopathy. The haemodynamic view.  Am J Med. 1986;  80 443-453
    CrossrefPubMedGoogle Scholar

Assoc. Prof. E. J. Diamantopoulos, M. D.

Oitis 10 · Paleo Psychiko · 154 52 Athens · Greece ·

Phone: +30(210)7258 862

Fax: +30(210)7258862

Email: gmar@ath.forthnet.gr

      >